Back
Seres Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
43
MCRB
Seres Therapeutics
Last Price:
0.80
Seasonality Move:
-5.38%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
Seres Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.79 | Buy |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 0.93 | Sell |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.19 | Sell |
Seres Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -1300848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Seres Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.80 while MCRB 8-day simple moving average is 0.76, which is a Buy signal.
- The stock price of MCRB is 0.80 while Seres Therapeutics 20-day SMA is 0.79, which makes it a Buy.
- Seres Therapeutics 50-day simple moving average is 0.88 while MCRB share price is 0.80, making it a Sell technically.
- MCRB stock price is 0.80 and Seres Therapeutics 200-day simple moving average is 0.93, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.80. The Score for MCRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
120.64M
Price in USD:
0.80
Share Volume:
1.46M
Seres Therapeutics 52-Week Range
52-Week High:
2.05
52-Week Low:
0.54
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 0.80 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.80 while MCRB 8-day exponential moving average is 0.79, which is a Buy signal.
- The stock price of MCRB is 0.80 while Seres Therapeutics 20-day EMA is 0.81, which makes it a Sell.
- Seres Therapeutics 50-day exponential moving average is 0.86 while MCRB share price is 0.80, making it a Sell technically.
- MCRB stock price is 0.80 and Seres Therapeutics 200-day simple moving average is 1.19, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Seres Therapeutics is a Sell
- Seres Therapeutics Relative Strength Index (RSI) is 46.77, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is ( - ), which suggest Seres Therapeutics is a Buy
- The Bollinger Bands (100) for Seres Therapeutics is ( - ), which suggest Seres Therapeutics is a Buy
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.